ArticleCell2024

A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells.

Victor Tieu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.